Inventor
Vineet PANDE
Inventor
BE
Overview
Patents· 10 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations28%
C07DHeterocyclic compounds28%
A61KPreparations for medical, dental or toiletry purposes22%
C07BGeneral methods of organic chemistry11%
C07HSugars11%
PatentTitleYear
12,473,295Substituted straight chain spiro derivatives202512,145,961Spirobicyclic analogues202412,084,462Spiro bicyclic inhibitors of menin-MLL interaction202411,993,614Monocyclic and bicyclic ring system substituted carbanucleoside analogues for use as PRMT5 inhibitors202411,883,3676-6 bicyclic aromatic ring substituted nucleoside analogues for use as PRMT5 inhibitors202411,702,441Spirobicyclic analogues202311,530,226Azepane inhibitors of menin-MLL interaction202211,396,517Exo-aza spiro inhibitors of menin-MLL interaction202211,318,1576-6 bicyclic aromatic ring substituted nucleoside analogues for use as PRMT5 inhibitors202211,220,517Spiro bicyclic inhibitors of menin-MLL interaction2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2025Patents assigned to JANSSEN PHARMACEUTICA NV (10)· patent assignee history
2022–2025Based in BE· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| JANSSEN PHARMACEUTICA NV | 10 | 2022–2025 |
Locations
| Location | Patents | Span |
|---|---|---|
| BE | 10 | 2022–2025 |